Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 85 | 0.91 |
| pathways Reactome | 2 pathways; mostly iron and oxidative stress | 0.80 |
No case: the score is under the bar. Receipt 9485
Sealed predictions
- MGST2 in dopamine neurons, braak-0.90 (p 0.001) → -0.25 (p 0.508)receipt 9493
Swarm cases
receipt 9493: MGST2 in dopamine neurons, braak
- power
- full sample -0.48 (p 0.043, n 18), 95% CI -0.77 to -0.02. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.49 (p 0.037, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.52 (p 0.026, n 18). not the mix.
- skeptic
- leave-one-out range -0.64 to -0.42, sign flips 0; without severely affected donors -0.48 (p 0.043, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MGST2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts